| Mar 1, 2025 |
Mar 4, 2025 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
92.5
|
+20,153
|
7.93%
|
✗
|
$635.8K |
| Mar 1, 2024 |
Mar 5, 2024 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
92.5
|
+15,589
|
8.04%
|
✗
|
$256.3K |
| Sep 5, 2023 |
Sep 6, 2023 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
22.5
|
-6,000
|
-10.47%
|
✗
|
$227.8K |
| Jun 19, 2023 |
Jun 21, 2023 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
48.8
|
-305
|
-0.53%
|
✗
|
$14.7K |
| Mar 1, 2023 |
Mar 3, 2023 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
95.0
|
+20,999
|
15.44%
|
✗
|
$165.8K |
| Jun 19, 2022 |
Jun 22, 2022 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
48.8
|
-295
|
-0.81%
|
✗
|
$16.2K |
| Mar 1, 2022 |
Mar 3, 2022 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
95.0
|
+11,287
|
45.09%
|
✗
|
$180.7K |
| Oct 14, 2021 |
Oct 18, 2021 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
46.3
|
-303
|
-1.20%
|
✗
|
$24.6K |
| Jul 6, 2021 |
Jul 8, 2021 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
46.3
|
-375
|
-1.46%
|
✗
|
$34.3K |
| Jun 19, 2021 |
Jun 23, 2021 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
37.5
|
-1,009
|
-3.78%
|
✓
|
$95.7K |
| May 6, 2021 |
May 10, 2021 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
41.3
|
-700
|
-2.55%
|
✓
|
$79.6K |
| Apr 20, 2021 |
Apr 21, 2021 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
48.8
|
-396
|
-1.42%
|
✓
|
$41.3K |
| Mar 1, 2021 |
Mar 3, 2021 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
97.5
|
+6,959
|
33.37%
|
✓
|
$439K |
| Jun 3, 2020 |
Feb 3, 2021 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
22.5
|
-2,516
|
-10.77%
|
✗
|
$187.9K |
| Oct 14, 2020 |
Oct 16, 2020 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
48.8
|
-220
|
-0.93%
|
✗
|
$19.4K |
| Jul 6, 2020 |
Jul 8, 2020 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
46.3
|
-260
|
-1.09%
|
✗
|
$22.6K |
| Jun 19, 2020 |
Jun 22, 2020 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
46.3
|
-303
|
-1.25%
|
✗
|
$23.7K |
| May 6, 2020 |
May 8, 2020 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
48.8
|
-209
|
-0.86%
|
✗
|
$13.8K |
| Apr 19, 2020 |
Apr 21, 2020 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
48.8
|
-210
|
-0.85%
|
✗
|
$12.3K |
| Mar 1, 2020 |
Mar 3, 2020 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
91.3
|
+10,263
|
71.72%
|
✗
|
$46.2K |
| Jul 6, 2019 |
Jul 9, 2019 |
Ultragenyx Pharmaceutical Inc.
|
EVP & Chief Commercial Officer |
Sell |
46.3
|
-260
|
-1.95%
|
✗
|
$15.5K |